These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37153573)

  • 1. Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis.
    Liao CY; Barrow F; Venkatesan N; Nakao Y; Mauer AS; Fredrickson G; Song MJ; Sehrawat TS; Dasgupta D; Graham RP; Revelo XS; Malhi H
    Front Immunol; 2023; 14():1130184. PubMed ID: 37153573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis.
    Mauer AS; Hirsova P; Maiers JL; Shah VH; Malhi H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G300-G313. PubMed ID: 28039158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis.
    Liao CY; Song MJ; Gao Y; Mauer AS; Revzin A; Malhi H
    Front Immunol; 2018; 9():2980. PubMed ID: 30619336
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrin β
    Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
    J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
    Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
    Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes.
    Geng T; Sutter A; Harland MD; Law BA; Ross JS; Lewin D; Palanisamy A; Russo SB; Chavin KD; Cowart LA
    J Lipid Res; 2015 Dec; 56(12):2359-71. PubMed ID: 26482537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis.
    Tomita K; Freeman BL; Bronk SF; LeBrasseur NK; White TA; Hirsova P; Ibrahim SH
    Sci Rep; 2016 Jun; 6():28786. PubMed ID: 27349927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis.
    Dohnalkova E; Bayer RL; Guo Q; Bamidele AO; Kim Lee HS; Valenzuela-Pérez L; Krishnan A; Pavelko KD; Guisot NES; Bunyard P; Kim YB; Ibrahim SH; Gores GJ; Hirsova P
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37267252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis.
    Hirsova P; Bohm F; Dohnalkova E; Nozickova B; Heikenwalder M; Gores GJ; Weber A
    Cell Death Dis; 2020 Feb; 11(2):80. PubMed ID: 32015322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
    Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
    Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.
    Hirsova P; Ibrahim SH; Bronk SF; Yagita H; Gores GJ
    PLoS One; 2013; 8(7):e70599. PubMed ID: 23894677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability.
    Li J; Sapper TN; Mah E; Moller MV; Kim JB; Chitchumroonchokchai C; McDonald JD; Bruno RS
    J Nutr Biochem; 2017 Mar; 41():34-41. PubMed ID: 28038359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis.
    Puengel T; Lefere S; Hundertmark J; Kohlhepp M; Penners C; Van de Velde F; Lapauw B; Hoorens A; Devisscher L; Geerts A; Boehm S; Zhao Q; Krupinski J; Charles ED; Zinker B; Tacke F
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.
    Lu Z; Li Y; Syn WK; Wang Z; Lopes-Virella MF; Lyons TJ; Huang Y
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E131-E144. PubMed ID: 31821039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H
    Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TREM2 levels reflect the recruitment and expansion of TREM2
    Hendrikx T; Porsch F; Kiss MG; Rajcic D; Papac-Miličević N; Hoebinger C; Goederle L; Hladik A; Shaw LE; Horstmann H; Knapp S; Derdak S; Bilban M; Heintz L; Krawczyk M; Paternostro R; Trauner M; Farlik M; Wolf D; Binder CJ
    J Hepatol; 2022 Nov; 77(5):1373-1385. PubMed ID: 35750138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.